← FDA Drug Approvals (Drugs@FDA)

PROLENSA

NDA · New Drug Application · Sponsor: BAUSCH AND LOMB · Approved 2013-04-05

Drug application

FDA Application #

NDA203168

Application type

New Drug Application

Brand name

PROLENSA

Generic name

BROMFENAC SODIUM

Active ingredients

BROMFENAC SODIUM

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

BAUSCH AND LOMB

Manufacturer

Bausch & Lomb Americas Inc.

First approval

2013-04-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown